ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
+8.45%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$17.4M
AUM Growth
+$17.4M
(-84%)
Cap. Flow
-$98.8M
Cap. Flow
% of AUM
-566.33%
Top 10 Holdings %
Top 10 Hldgs %
70.1%
Holding
52
New
9
Increased
–
Reduced
16
Closed
27
Top Buys
| 1 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$1.55M |
| 2 |
Icon
ICLR
|
$1.04M |
| 3 |
Labcorp
LH
|
$906K |
| 4 |
Encompass Health
EHC
|
$859K |
| 5 |
Pfizer
PFE
|
$455K |
Top Sells
| 1 |
BioMarin Pharmaceuticals
BMRN
|
$16.9M |
| 2 |
Bruker
BRKR
|
$6.93M |
| 3 |
AstraZeneca
AZN
|
$6.53M |
| 4 |
Thermo Fisher Scientific
TMO
|
$5.34M |
| 5 |
Elevance Health
ELV
|
$5.13M |
Sector Composition
| 1 | Healthcare | 98.36% |
| 2 | Real Estate | 1.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
10x Genomics
TXG
$1.66B
| – | – |
-71,044
| Closed | -$2.93M |
|
52
Ventyx Biosciences
VTYX
$184M
| – | – |
-18,458
| Closed | -$641K |
|